Evommune Stock Forecast

Stock Price Forecast

According to 3 professional analysts, the 12-month price target for Evommune stock ranges from a low of $36 to a high of $42. The average analyst price target of $39.33 forecasts a 79.59% increase in the stock price over the next year.

Price Target: $39.33 (+79.59%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$36	$39.33	$40	$42
Change	+64.38%	+79.59%	+82.65%	+91.78%

Analyst Ratings

The average analyst rating for Evommune stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25
Strong Buy	0
Buy	5
Hold	0
Sell	0
Strong Sell	0
Total	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matt Phipps William Blair	William Blair	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Dec 1, 2025
Prakhar Agrawal Cantor Fitzgerald	Cantor Fitzgerald	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Dec 1, 2025
Judah Frommer Morgan Stanley	Morgan Stanley	Buy Initiates $36	Buy	Initiates	$36	+64.38%	Dec 1, 2025
Thomas Smith Leerink Partners	Leerink Partners	Buy Initiates $42	Buy	Initiates	$42	+91.78%	Dec 1, 2025
Gavin Clark-Gartner Evercore ISI Group	Evercore ISI Group	Buy Initiates $40	Buy	Initiates	$40	+82.65%	Dec 1, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

EPS Next Year

n/a

No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.